Clinical Trial Update: Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study [Phase 2]

View source ↗

Summary

Mayo Clinic sponsors a Phase 2 trial (SAGA) evaluating short-course radiotherapy for glioblastoma; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Snippet

Sponsor: Mayo Clinic | Conditions: Glioblastoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING